Article
Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
Journal of cancer research and clinical oncology - 1 May 2015
Mota P, Silva H C, Soares M J, Pego A, Loureiro M, Cordeiro C Robalo, Regateiro F J
Abstract excerpt
OBJECTIVES: Tobacco exposure remains the main etiologic factor for lung cancer (LC). Interactions between environment and individual genetic profile are particularly important for this disease. The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, CYP2D6*4, GSTP1, GSTM1, GSTT1 and NAT2 polymorphisms for the susceptibility to LC in a Portuguese population considering their demographic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
